Expression and regulation of tumor suppressor gene maspin in human bladder cancer

Cancer Letters

Volumn 203, Issue 2, 2004, Pages 209-215

  Sugimoto, Shuji ^a   Maass, Nicolai ^a   Takimoto, Yukie ^b   Sato, Katsuhiko ^b   Minei, Sadatsugu ^b   Zhang, Ming ^c   Hoshikawa, Yutaka ^d   Jünemann, Klaus Peter ^a   Jonat, Walter ^a   Nagasaki, Koichi ^a,d  

^a UNIVERSITY OF KIEL   (Germany)

^b NIHON UNIVERSITY   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CANCER INSTITUTE   (Japan)

Author keywords

5 Aza 2 deoxycytidine; Bladder cancer; DNA methylation; Histone deacetylation; Maspin; Transitional cell carcinoma; Trichostatin A

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MASPIN; TRICHOSTATIN A;

AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER SURGERY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCLE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

EID: 9144258612     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.09.010     Document Type: Article

References (26)

1. Herr H.W. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J. Urol. 163:2000;60-62.
2. Reiher F., Ozer O., Pins M., Jovanovic B.D., Eggener S., Campbell S.C. p53 and microvessel density in primary resection specimens of superficial bladder cancer. J. Urol. 167:2002;1469-1474.
3. Yuge F., Hirakata H., Kodama M., Kawata N., Takimoto Y. Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma. Hinyokika. Kiyo. 45:1999;453-456.
4. Gontero P., Tizzani A., Muir G.H., Caldarera E., Macaluso M.P. The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value. Urol. Res. 29:2001;377-387.
5. Zou Z., Anisowicz A., Hendrix M.J.C., Thor A., Neveu M., Sheng S., et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:1994;526-529.
6. Maass N., Teffner M., Rösel F., Pawaresch R., Jonat W., Nagasaki K., Rudolph P. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J. Pathol. 195:2001;321-326.
7. Zou Z., Zhang W., Young D., Gleave M.G., Rennie P., Connell T., et al. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of maspin expression by androgen ablation. Clin. Cancer Res. 8:2002;1172-1177.
8. Song S.Y., Lee S.K., Kim D.H., Son H.J., Kim H.J., Lim Y.J., et al. Expression of maspin in colon cancers its relationship with p53 expression and microvessel density. Dig. Dis. Sci. 47:2002;1831-1835.
9. Xia W., Lau Y., Hu M.C.-T., Li L., Johnston D.A., Sheng S., et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 19:2000;2398-2403.
10. Umekita Y., Hiipakka R.A., Liao S. Rat and human maspin: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Lett. 113:1997;87-93.
11. Fleming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J., Murphy G.P. AJCC cancer staging manual. 1997;Lippincott Raven, Philadelphia.
12. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22:1998;1435-1438.
13. Maass N., Biallek M., Rösel F., Schem C., Ohike N., Zhang M., et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem. Biophys. Res. Commun. 297:2002;125-128.
14. Maass N., Hojo T., Rösel F., Ikeda T., Jonat W., Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin. Biochem. 34:2001;303-307.
15. Hemal A.K., Khaitan A., Dinda A.K., Gupta N.P., Seth A., Dogra P.N., Nabi G. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy. Urol. Int. 70:2003;42-46.
16. Maass N., Hojo T., Ueding M., Lüettges J., Kloeppel G., Jonat W., Nagasaki K. Expression of tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 7:2001;812-817.
17. Maass N., Nagasaki K., Teffner M., Mundhenke C., Jonat W. Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin. Breast Cancer. 3:2002;281-287.
18. Futscher B.W., Oshiro M.M., Wozniak R.J., Holtan N., Hanigan C.L., Duan H., Domann F.E. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31:2002;175-179.
19. Colquhoun A.J., Jones G.D., Moneef M.A., Bowman K.J., Kockelbergh R.C., Symods R.P., et al. Improving and predicting radiosensitivity in muscle invasive bladder cancer. J. Urol. 169:2003;1983-1992.
20. Son H.J., Sohn T.S., Song S.Y., Lee J.H., Rhee J.C. Maspin expression in human gastric adenocarcinoma. Pathol. Int. 52:2002;508-513.
21. Sood A.K., Fletcher M.S., Gruman L.M., Coffin J.E., Jabbari S., Khalkhali-Ellis Z., et al. The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 8:2002;2924-2932.
22. Machtens S., Serth J., Bokemeyer C., Bathke W., Minssen A., Kollmannsberger C., et al. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int. J. Cancer. 95:2001;337-342.
23. McShane L.M., Aamodt R., Cordon-Cardo C., Cote R., Faraggi D., Fradet Y., et al. The National Cancer Institute Bladder Tumor Marker Network, Reproducibility of p53 immunohistochemistry in bladder tumors. Clin. Cancer Res. 6:2000;1854-1864.
24. Tiguert R., Lessard A., So A., Fradet Y. Prognostic markers in muscle invasive bladder cancer. World J. Urol. 20:2002;190-195.
25. Zou Z., Gao C., Nagaich A.K., Connell T., Saito S., Moul J.W., et al. p53 regulates the expression of the tumor suppressor gene maspin. J. Biol. Chem. 275:2000;6051-6054.
26. Zhang M., Maass N., Magit D., Sager R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ. 8:1997;179-186.